In the first half of its 2018 financial year, RWS posts revenues of GBP 139.6m and a pre-tax profit of GBP 28.6m. While acquisitions drive revenue growth, the core patent translation business generates the majority of profits. Shares pop 10% following the results. Continue reading
Massive privacy breach at Translate.com, senior managers leaving TransPerfect in droves, RWS buying Moravia, Facebook launching neural machine translation, Pearl Linguistic going bust, and more than two dozen other stories that lit up the Slator website in 2017. Continue reading
At SlatorCon Zurich 2017, Dr Christoph Bieri, Managing Partner of the M&A firm that advised LUZ on its sale to RWS, shared his experience on choosing buyers, determining valuation and managing due diligence and explained why a medicine is a molecule connected to a huge amount of documentation. Continue reading
In 2018, Moravia will contribute half of RWS Group’s revenues. The China patent business continues to grow as ZTE and Huawei emerge as the world’s busiest patent filers. And the bet on life sciences is paying off. Continue reading
RWS registered its best ever revenue and profits figures in FY 2017 and declared its 14th consecutive dividend increase. Recent acquisitions in Life Sciences contribute significantly to the bottom line. Continue reading
RWS reports 33.6% revenue growth and projects pre-tax profits “ahead of market expectations” for its financial year ending September 30, 2017. Market capitalization nears USD 1.3bn on the back of surge in share price. Continue reading
RWS delivers yet another set of strong results as share price hovers near all-time high. Revenues are up 35% and operating profits up 28% in the first six months of the financial year. Chairman Andrew Brode says they occasionally compete with TransPerfect but would never consider buying them. Continue reading
Shares in UK language service provider surge on back of trading update. RWS market capitalization breaks through one-billion-US-dollar mark. Continue reading
Another Swiss-based language service provider changes hands as more and more outside competitors move into the high-priced Swiss market. Apostroph CEO Philipp Meier to remain and become shareholder in combined group. Continue reading
One of the most attractive pure-play, life sciences players changes hands as RWS bolsters position in fast-growing vertical. Price tag in line with 2015 acquisition of CTi. Continue reading
ULG appoints KJI co-founder Strategic Director of Global Operations. Aspena BDM moves to New York and becomes Managing Director. LUZ names a new Account Director. Architekst fills a BDM post. And Straker Translations appoints a Strategic Account Manager. Continue reading
A closer look at two recent partnership announcements. Lionbridge teams up with Transifex to fill a gap in its tech stack, while life science language service provider LUZ goes after TransPerfect by partnering with Phlexglobal on clinical trial solutions. Continue reading
After legal and digital marketing, Welocalize pushes into life sciences with the acquisition of Nova Language Services, adding another roughly EUR 5m in revenues to its group of companies. Continue reading
This week’s people moves in the language industry sees new director, business development, and bid manager hires, among others, at LUNA, Haymillian, LUZ, Moravia, Morningside Translations, ProTranslating, Capita TI, LanguageWire, and Lingotek. Continue reading
This information will never be shared with third parties. No Spam.